Dr. Martins Silva is a resident in the Department of Radiation Oncology, Hospital de Braga, Portugal. Dr. Fardilha is a board-certified specialist in the Department of Radiation Oncology, Hospital de Braga, and the Department of Radiation Oncology, Institute CUF Porto – Júlio Teixeira, SA, Portugal. Dr. Freitas is a board-certified specialist in the Department of Clinical Oncology, Hospital de Braga. Dr. Fonseca is a board-certified specialist in the Department of Radiation Oncology, Hospital de Braga and Department of Radiation Oncology, Institute CUF Porto – Júlio Teixeira, SA. Dr. Louro is a resident in the Department of Radiation Oncology, Hospital de Braga. Dr. Costa is the department chair in the Department of Radiation Oncology, Hospital de Braga and Department of Radiation Oncology, Institute CUF Porto – Júlio Teixeira, SA. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. This case report was presented as a poster at Encontros da Primavera 2019, April 10-13 in Evora, Portugal, under the title Abscopal effect of radiation therapy in monotherapy in the case of metastatic malignant melanoma: a case report.
Dr. Murphy is a senior house officer in radiation oncology and Dr. Gillham is consultant radiation oncologist at St. Luke’s Radiation Oncology Centre, St. James’s Hospital, Dublin, Ireland. Disclosure/informed consent: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. The patient has provided informed consent for the publication of this case report.
Mr. Moser is a fourth-year medical student, and Dr. Stokes is a radiation oncologist, Southeast Alabama Medical Center, Dothan, AL. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.
Mr. Hatheway is an MSIII at the University of Pittsburgh School of Medicine, Pittsburgh, PA. Dr. Holt is a PGY1 in the Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City. Dr. Gebhardt is a PGY4 in the Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA. Dr. Heron is director of radiation services at UPMC Cancer Center, chairman of the Department of Radiation Oncology, and professor of the Departments of Otolaryngology and Head and Neck Surgery at UPMC Shadyside, Pittsburgh, PA. Dr. Ohr is an assistant clinical professor of medicine at the University of Pittsburgh School of Medicine, Pittsburgh, PA. Dr. Ferris is chief of the Division of Head and Neck Surgery at the University of Pittsburgh School of Medicine Department of Radiation Oncology, Pittsburgh, PA. Dr. Clump is an attending radiation oncologist at University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, PA.
Mr. Hill is a medical student; Drs. Trifiletti and Romano are residents; and Dr. Showalter is associate professor; Department of Radiation Oncology, University of Virginia, Charlottesville. Dr. Sheehan is professor, Department of Radiation Oncology and Department of Neurological Surgery, University of Virginia, Charlottesville.